Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1

被引：6
|
作者：
Kalambokis, Georgios N. [1 ]
Baltayiannis, Gerasimos [2 ]
Christodoulou, Dimitrios [2 ]
Christou, Leonidas [1 ]
机构：
[1] Univ Ioannina, Med Sch, Div Internal Med 1, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Med Sch, Dept Gastroenterol, Ioannina, Greece
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2017年 / 29卷 / 12期
关键词：
MANAGEMENT; CIRRHOSIS; ALBUMIN; ASCITES;
D O I：
10.1097/MEG.0000000000000988
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1428 / 1429
页数：2
相关论文
共 50 条
  • [1] TERLIPRESSIN VERSUS MIDODRINE/OCTREOTIDE FOR HEPATORENAL SYNDROME
    Juang, Paul
    Yeary, Julianne
    Barker, Skyler
    Owen, Emily
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [2] Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
    Angeli, P
    Volpin, R
    Gerunda, G
    Craighero, R
    Rone, P
    Merenda, R
    Amodio, P
    Sticca, A
    Caregaro, L
    Maffei-Faccioli, A
    Gatta, A
    HEPATOLOGY, 1999, 29 (06) : 1690 - 1697
  • [3] Reversal of type 1 hepatorenal syndrome (HRS) with the combined administration of midodrine and octreotide
    Angeli, P
    Volpin, R
    Gerunda, G
    Craighero, R
    Con, P
    Caregaro, L
    Cameriero, V
    Sticca, A
    MaffeiFaccioli, A
    Gatta, A
    HEPATOLOGY, 1997, 26 (04) : 635 - 635
  • [4] Efficacy of Midodrine, Octreotide and Albumin (MOA) for Type I Hepatorenal Syndrome (HRS 1)
    Liu, Eashen
    Singhal, Pooja
    Karim, Yasmin K.
    Barton, Franca B.
    Lewis, James H.
    GASTROENTEROLOGY, 2011, 140 (05) : S959 - S959
  • [5] Terlipressin for Type 1 Hepatorenal Syndrome
    Terbah, R.
    Gow, P.
    Sinclair, M.
    Testro, A.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (08) : 2454 - 2455
  • [6] Terlipressin for type 1 hepatorenal syndrome
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (05): : 347 - 347
  • [7] Terlipressin for Type 1 Hepatorenal Syndrome
    R. Terbah
    P. Gow
    M. Sinclair
    A. Testro
    Digestive Diseases and Sciences, 2020, 65 : 2454 - 2455
  • [8] Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
    Wong, F
    Pantea, L
    Sniderman, K
    HEPATOLOGY, 2004, 40 (01) : 55 - 64
  • [9] TREATMENT OF HEPATORENAL SYNDROME WITH OCTREOTIDE ALBUMIN AND MIDODRINE
    Jain, Akhil
    Hunsicker, Lawrence G.
    Voigt, Michael D.
    HEPATOLOGY, 2008, 48 (04) : 1086A - 1086A
  • [10] Vasoactive treatment of hepatorenal syndrome type 1 (HRS1) with midodrine, octreotide and albumin
    Schepke, M
    Malayeri, H
    Heller, J
    Sauerbruch, T
    GASTROENTEROLOGY, 2003, 124 (04) : A664 - A664
12345